148 related articles for article (PubMed ID: 15750928)
1. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
[TBL] [Abstract][Full Text] [Related]
2. Novel peptides secreted from human neuroblastoma: useful clinical tools?
Sandoval JA; Hoelz DJ; Woodruff HA; Powell RL; Jay CL; Grosfeld JL; Hickeyd RJ; Malkas LH
J Pediatr Surg; 2006 Jan; 41(1):245-51. PubMed ID: 16410142
[TBL] [Abstract][Full Text] [Related]
3. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of neuroblastoma subtypes in response to mitogen-activated protein kinase inhibition: profiling multiple targets of cancer kinase signaling.
Sandoval JA; Eppstein AC; Hoelz DJ; Klein PJ; Linebarger JH; Turner KE; Rescorla FJ; Hickey RJ; Malkas LH; Schmidt CM
J Surg Res; 2006 Jul; 134(1):61-7. PubMed ID: 16650873
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomic analysis of human CD34+ stem/progenitor cells and mature CD15+ myeloid cells.
Tao W; Wang M; Voss ED; Cocklin RR; Smith JA; Cooper SH; Broxmeyer HE
Stem Cells; 2004; 22(6):1003-14. PubMed ID: 15536191
[TBL] [Abstract][Full Text] [Related]
6. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
7. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
[TBL] [Abstract][Full Text] [Related]
8. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
9. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
Yocum AK; Busch CM; Felix CA; Blair IA
J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
[TBL] [Abstract][Full Text] [Related]
11. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional separations of the genome and proteome of neuroblastoma cells.
Wimmer K; Kuick R; Thoraval D; Hanash SM
Electrophoresis; 1996 Nov; 17(11):1741-51. PubMed ID: 8982607
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic expression profile in all-trans retinoic acid differentiated neuroblastoma cell line.
Cimmino F; Spano D; Capasso M; Zambrano N; Russo R; Zollo M; Iolascon A
J Proteome Res; 2007 Jul; 6(7):2550-64. PubMed ID: 17559250
[TBL] [Abstract][Full Text] [Related]
15. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
16. [Comparative proteomics analysis of differentially expressed metastasis-associated proteins in human ovarian cancer cell lines].
Su D; Xu SH; Gu LH
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):619-22. PubMed ID: 16202319
[TBL] [Abstract][Full Text] [Related]
17. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
18. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage.
Baruthio F; Quadroni M; Rüegg C; Mariotti A
Proteomics; 2008 Nov; 8(22):4733-47. PubMed ID: 18942674
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of neuroblastoma microenvironment: effect of the host-tumor interaction on disease progression.
Turner KE; Kumar HR; Hoelz DJ; Zhong X; Rescorla FJ; Hickey RJ; Malkas LH; Sandoval JA
J Surg Res; 2009 Sep; 156(1):116-22. PubMed ID: 19592021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
